Australian-based, Asia-Pacific focused CRO Novotech has formed a partnership with the Skin Research Institute of Singapore (SRIS) to enhance quality research opportunities in Asia.
Skin Research Institute of Singapore (SRIS)
SRIS was established as a collaboration between the Agency for Science Technology and Research (A *STAR ), National Healthcare Group (NHG) and Nanyang Technological University. Launched in 2013, the research center harnesses the expertise of scientists, clinicians, and engineers to foster and conduct high impact, inter-disciplinary skin research that would translate into improved health outcomes and quality of life. SRIS supports a wide range of clinical research involving dermatology research—they maintain deep research expertise.
Goal of the Partnership
The two parties seek to formalize what has already been a long-standing working relationship. The partnership will support both parties to forge even closer collaboration to ensure high-quality priority start-up of new clinical trials—as well as increase ties in areas of clinical research promotion, business development, clinical operations, training, and feasibility assessments. The two parties will jointly promote SRIS clinical trials.
Growing Demand for Skin Disorder Studies
The parties have formalized their alliance in part due to growing business demand for dermatology-related clinical trials in the Asian region. Novotech has offices in 11 countries and more than 600 staff to help support industry sponsors.
A leading regional CRO, based in Australia with offices in 11 countries with a focus in Asia. A full-service operation, Novotech has been instrumental in hundreds of Phase I-IV clinical trials in the Asia Pacific region.